These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22175514)

  • 1. Steady advance of stem cell therapies: report from the 2011 World Stem Cell Summit, Pasadena, California, October 3-5.
    Swan M
    Rejuvenation Res; 2011 Dec; 14(6):699-704. PubMed ID: 22175514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic cell reprogramming as a tool for neurodegenerative diseases.
    Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M
    Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Geron's clinical trial for spinal cord injury.
    Lukovic D; Stojkovic M; Moreno-Manzano V; Bhattacharya SS; Erceg S
    Stem Cells Dev; 2014 Jan; 23(1):1-4. PubMed ID: 23980630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regenerative cellular therapies for neurologic diseases.
    Levy M; Boulis N; Rao M; Svendsen CN
    Brain Res; 2016 May; 1638(Pt A):88-96. PubMed ID: 26239912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].
    Nakamura M; Toyama Y; Okano H
    Rinsho Shinkeigaku; 2013; 53(11):1013-5. PubMed ID: 24291863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem Cells - SMi's second annual conference: achieving success in science and commercialisation.
    Lucifero D
    IDrugs; 2010 Apr; 13(4):232-4. PubMed ID: 20373250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Pluripotent Stem Cells-Based Therapies for Neurodegenerative Diseases: Current Status and Challenges.
    Ford E; Pearlman J; Ruan T; Manion J; Waller M; Neely GG; Caron L
    Cells; 2020 Nov; 9(11):. PubMed ID: 33233861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation.
    Lewandowski J; Kurpisz M
    Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):349-70. PubMed ID: 26939778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.
    Drugs R D; 2006; 7(3):197-201. PubMed ID: 16752945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regenerative Medicine: Advances from Developmental to Degenerative Diseases.
    Blair NF; Frith TJR; Barbaric I
    Adv Exp Med Biol; 2017; 1007():225-239. PubMed ID: 28840560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2010 World Stem Cell Summit--part 2. October 4-6, 2010, Detroit, MI, USA.
    Vertès A
    IDrugs; 2010 Dec; 13(12):822-4. PubMed ID: 21154133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fifth Annual Stem Cell Summit.
    Knowlton D
    IDrugs; 2010 Apr; 13(4):235-8. PubMed ID: 20373251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell and tissue therapy in regenerative medicine.
    Sánchez A; Schimmang T; García-Sancho J
    Adv Exp Med Biol; 2012; 741():89-102. PubMed ID: 22457105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-based therapy approaches: the hope for incurable diseases.
    Buzhor E; Leshansky L; Blumenthal J; Barash H; Warshawsky D; Mazor Y; Shtrichman R
    Regen Med; 2014; 9(5):649-72. PubMed ID: 25372080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapeutic strategies using nanodrug delivery, stem cells and combination therapy for CNS trauma and neurodegenerative disorders.
    Sharma HS; Muresanu DF; Sharma A
    Expert Rev Neurother; 2013 Oct; 13(10):1085-8. PubMed ID: 24089700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regenerative therapy for post-stroke patients].
    Yamashita T; Abe K
    Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of transcription factors in cell replacement therapies for neurodegenerative conditions.
    Thomas M
    Regen Med; 2010 May; 5(3):441-50. PubMed ID: 20455654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem Cell Technology for (Epi)genetic Brain Disorders.
    Riemens RJM; Soares ES; Esteller M; Delgado-Morales R
    Adv Exp Med Biol; 2017; 978():443-475. PubMed ID: 28523560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases].
    Ito D; Yagi T; Suzuki N
    Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.